Sarcoplasmic reticulum Ca2+ transport and gene expression in congestive heart failure are modified by imidapril treatment

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 288, Issue 4 57-4, 2005, Pages

  Shao, Qiming ^a   Ren, Bin ^a   Saini, Harjot K ^a   Netticadan, Thomas ^a   Takeda, Nobuakira ^b   Dhalla, Naranjan S ^a,c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

Author keywords

Cardiac gene expression; Myocardial infarction; Renin angiotensin system

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM ION; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; IMIDAPRIL; LOSARTAN; MESSENGER RNA; PHOSPHOLAMBAN; RYANODINE RECEPTOR; ANTIHYPERTENSIVE AGENT; CALCIUM; DIAGNOSTIC AGENT; IMIDAZOLIDINE DERIVATIVE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; GENE EXPRESSION; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART PERFORMANCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SARCOPLASMIC RETICULUM; TREATMENT OUTCOME; ANIMAL; CARDIOMEGALY; GENETICS; HEART VENTRICLE PRESSURE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIHYPERTENSIVE AGENTS; CALCIUM; CALCIUM-TRANSPORTING ATPASES; CARDIOMEGALY; ENALAPRIL; GENE EXPRESSION; HEART FAILURE, CONGESTIVE; IMIDAZOLIDINES; LOSARTAN; MALE; MYOCARDIAL INFARCTION; RATS; RATS, SPRAGUE-DAWLEY; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; TRITIUM; VENTRICULAR PRESSURE;

EID: 16844383531     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00945.2004     Document Type: Article

References (45)

1. Afzal N and Dhalla NS. Differential changes in left and right ventricular SR calcium transport in congestive heart failure. Am J Physiol Heart Circ Physiol 262: H868-H874, 1992.
2. 2+ pump ATPase activity in congestive heart failure due to myocardial infarction. Can J Cardiol 12: 1065-1073, 1996.
3. Ambrose J, Pribnow DG, Giraud GD, Perkins KD, Muldoon L, and Greenberg BH. Angiotensin type 1 receptor antagonism with irbesartan inhibits ventricular hypertrophy and improves diastolic function in the remodeling post-myocardial infarction ventricle. J Cardiovasc Pharmacol 33: 433-439, 1999.
4. Arai M, Alpert NR, MacLennan DH, Barton P, and Periasamy M. Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res 72: 463-469, 1993.
5. Arai M, Matsui H, and Periasamy M. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ Res 74: 555-564, 1994.
6. Basu S, Sinha SK, Shao Q, Ganguly PK, and Dhalla NS. Neuropeptide Y modulation of sympathetic activity in myocardial infarction. J Am Coll Cardiol 27: 1796-1803, 1996.
7. 2+ ATPase type 2 (SERCA2) in cardiac sarcoplasmic reticulum from rabbits with heart failure. Cardiovasc Res 41: 135-146, 1999.
8. Dhalla NS, Das PK, and Sharma GP. Subcellular basis of cardiac contractile failure. J Mol Cell Cardiol 10: 363-385, 1978.
9. Dhalla NS, Golfman L, Takeda S, Takeda N, and Nagano N. Evidence for the role of oxidative stress in acute ischemic heart disease: a brief review. Can J Cardiol 15: 587-593, 1999.
10. Dhalla NS, Shao Q, and Panagia V. Remodeling of cardiac membranes during the development of congestive heart failure. Heart Fail Rev 2: 261-272, 1998.
11. Dhalla NS, Wang X, and Beamish RE. Intracellular calcium handling in normal and failing hearts. Exp Clin Cardiol 1: 7-20, 1996.
12. Fabiato A. Computer programs for calculating total from specified free or free from specified total ionic concentrations in aqueous solutions containing multiple metals and ligands. Methods Enzymol 157: 378-417, 1988.
13. Feldman AM, Weinberg EO, Ray PE, and Lorell BH. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ Res 73: 184-192, 1993.
14. Fraccarollo D, Galuppo P, Hildemann S, Christ M, Ertl G, and Bauersachs J. Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with epleronone and ACE inhibition in rats with myocardial infarction. J Am Coll Cardiol 42: 1666-1673, 2003.
15. Gohlke P, Linz W, Scholkens BA, Kuwer I, Bartenbach S, Schnell A, and Unger T. Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin. Hypertension 23: 411-418, 1994.
16. Guo X, Chapman D, and Dhalla NS. Partial prevention of changes in SR . gene expression in congestive heart failure due to myocardial infarction by enalapril or losartan. Mol Cell Biochem 254: 163-172, 2003.
17. 2+-uptake and expression of phospholamban in left ventricular myocardium of dogs with heart failure. J Mol Cell Cardiol 31: 1381-1389, 1999.
18. 2+ ATPase in failing and nonfailing human myocardium. Circ Res 75: 434-442, 1994.
19. Hashida H, Hamada M, and Hiwada K. Serial changes in sarcoplasmic reticulum gene expression in volume-overloaded cardiac hypertrophy in the rat: effect of an angiotensin II receptor antagonist. Clin Sci (Lond) 96: 387-395, 1999.
20. Hayakari M, Kondo Y, and Izumi H. A rapid and simple spectrophotometric assay of angiotensin-converting enzyme. Anal Biochem 84: 361-369, 1978.
21. Hirata Y, Hayakawa H, Kakoki M, Tojo A, Suzuki E, Kimura K, Goto A, Kikuchi K, Nagano T, Hirobe M, and Omata M. Nitric oxide release from kidneys of hypertensive rats treated with imidapril. Hypertension 27: 672-678, 1996.
22. Hosoya K and Ishimitsu T. Protection of the cardiovascular system by imidapril, a versatile angiotensin-converting enzyme inhibitor. Cardiovasc Drug Rev 20: 93-110, 2002.
23. Houser SR, Piacentino V III, and Weisser J. Abnormalities of calcium cycling in the hypertrophied and failing heart. J Mol Cell Cardiol 32: 1595-1602, 2000.
24. Iijima K, Geshi E, Nomizo A, Arata Y, and Katagiri T. Alterations in sarcoplasmic reticulum and angiotensin II type I receptor gene expression after myocardial infarction in rats. Jpn Circ J 62: 449-454, 1998.
25. Khaper N and Singal PK. Modulation of oxidative stress by a selective inhibition of angiotensin II type 1 receptors in MI rats. J Am Coll Cardiol 37: 1461-1466, 2001.
26. 2+ transport and mechanics in compensated pressure-overload hypertrophy and congestive heart failure. Circ Res 77: 759-764, 1995.
27. 2+-ATPase in failing and nonfailing human hearts. Cardiovasc Res 31: 625-632, 1996.
28. Morgan JP. Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction. N Engl J Med 325: 625-632, 1991.
29. 2+/calmodulin-dependent protein kinase is altered in heart failure. Circ Res 86: 596-605, 2000.
30. Okuda S, Yano M, Doi M, Oda T, Tokuhisa T, Kohno M, Kobayashi S, Yamamoto T, Ohkusa T, and Matsuzaki M. Valsartan restores sarcoplasmic reticulum function with no appreciable effect on resting cardiac function in pacing-induced heart failure. Circulation 109: 911-919, 2004.
31. Osada M, Netticadan T, Tamura K, and Dhalla NS. Modification of ischemia-reperfusion-induced changes in cardiac sarcoplasmic reticulum by preconditioning. Am J Physiol Heart Circ Physiol 274: H2025-H2034, 1998.
32. Pennock GD, Spooner PH, Summers CE, and Litwin SE. Prevention of abnormal sarcoplasmic reticulum calcium transport and protein expression in postinfarction heart failure using 3,5-diiodothyropropionic acid (DITPA). J Mol Cell Cardiol 32: 1939-1953, 2000.
33. 2+-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation 92: 3320-3328, 1995.
34. 2+-transport in heart failure due to myocardial infarction. J Mol Cell Cardiol 31: 1663-1672, 1999.
35. Takeishi Y, Bhagwat A, Ball NA, Kirkpatrick DL, Periasamy M, and Walsh RA. Effect of angiotensin-converting enzyme inhibition on protein kinase C and SR proteins in heart failure. Am J Physiol Heart Circ Physiol 276: H53-H62, 1999.
36. Tappia PS, Liu SY, Shatadal S, Takeda N, Dhalla NS, and Panagia V. Changes in sarcolemmal PLC isoenzymes in postinfarct congestive heart failure: partial correction by imidapril. Am J Physiol Heart Circ Physiol 277: H40-H49, 1999.
37. Wang J, Liu X, Ren B, Rupp H, Takeda N, and Dhalla NS. Modification of myosin gene expression by imidapril in failing heart due to myocardial infarction. J Mol Cell Cardiol 34: 847-857, 2002.
38. Wang J, Liu X, Sentex E, Takeda N, and Dhalla NS. Increased expression of protein kinase C isoforms in heart failure due to myocardial infarction. Am J Physiol Heart Circ Physiol 284: H2277-H2287, 2003.
39. Xu YJ, Chapman D, Dixon IM, Sethi R, Guo X, and Dhalla NS. Differential gene expression in infarct scar and viable myocardium from rat heart following coronary ligation. J Cell Mol Med 8: 85-92, 2004.
40. Yamaguchi F, Sanba A, and Takeo S. Cardiac sarcoplasmic reticular function in rats with chronic heart failure following myocardial infarction. J Mol Cell Cardiol 29: 753-763. 1997.
41. Yamaguchi F, Sanbe A, and Takeo S. Effects of long-term treatment with trandolapril on sarcoplasmic reticulum function of cardiac muscle in rats with chronic heart failure following myocardial infarction. Br J Pharmacol 123: 326-334, 1998.
42. Yoshiyama M, Takeuchi K, Hanatani A, Shimada T, Takemoto Y, Shimizu N, Omura T, Kim S, Iwao H, and Yoshikawa J. Effect of cilazapril on ventricular remodeling assessed by Doppler-echocardiographic assessment and cardiac gene expression. Cardiovasc Drugs Ther 12: 57-70, 1998.
43. Yu CH, Panagia V, Tappia PS, Liu SY, Takeda N, and Dhalla NS. Alterations of sarcolemmal phospholipase D and phosphatidate phosphohydrolase in congestive heart failure. Biochim Biophys Acta 1584: 65-72, 2002.
44. 2+-pump ATPase in congestive heart failure due to myocardial infarction. Mol Cell Biochem 163/164: 285-290, 1996.
45. 1-receptor blockade. Cardiovasc Res 31: 758-768, 1996.